Federal Register of Legislation - Australian Government

Primary content

PB 36 of 2022 Determinations/Health as made
This instrument amends the National Health (Continued Dispensing – Emergency Measures) Determination 2020 to make changes to the pharmaceutical benefits eligible to be provided as a Continued Dispensing supply to reflect amendments to the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012), which commence on the same day.
Administered by: Health
Registered 29 Apr 2022
Table of contents.

Commonwealth Coat of Arms of Australia

 

 

PB 36 of 2022

 

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 4)

I, CAROLINE TURNOUR, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.

Dated               28 April 2022

 

 

 

 

CAROLINE TURNOUR

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

 

 

 

 

 

 

                                           


 

 

 

Contents

1           Name…………………………………………………………………………….………………1

2.......... Commencement............................................................................................................................ 1

3.......... Authority...................................................................................................................................... 1

4 ......... Schedule....................................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

 

 

 


1        Name

(1)          This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2022 (No. 4).

(2)          This instrument may also be cited as PB 36 of 2022.

2        Commencement

(1)          Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 May 2022

1 May 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3        Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4        Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]        Schedule 1, after entry for Anastrozole

            insert:

Apalutamide

Tablet 60 mg

Oral

[2]        Schedule 1, after entry for Budesonide in the form Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2

            insert:

 

Tablet 1 mg (orally disintegrating)

Oral

 

Tablet 500 micrograms (orally disintegrating)

Oral

[3]        Schedule 1, entry for Desmopressin

omit:

 

Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations,
5 mL

Nasal

[4]        Schedule 1, after entry for Triglycerides ‑ medium chain, formula in the form Oral liquid 500 mL, 8 (Nutrini Peptisorb)

insert:

 

Oral liquid 500 mL, 12 (Nutrini Peptisorb)

Oral

[5]        Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert:

 

Tablet 1 mg (as tartrate) (s19A)

Oral